Age Reversal Technologies

Cellular reprogramming, senolytics, stem cell therapy, gene therapy, and other interventions being studied as longevity technologies. Evidence levels tracked.

Age reversal technologies are interventions designed to slow, stop, or reverse biological aging at the cellular and molecular level. The field ranges from compounds in early laboratory research to therapies in human clinical trials. This hub tracks each technology's research status, evidence level, and where the science currently stands.

Cellular Reprogramming

Using transcription factors (Yamanaka factors) to partially or fully reset a cell's epigenetic age. Shows strong results in animal studies. Human safety data is very limited.

Early-stage / research Epigenetic reprogramming Read more →

Senolytics

Drugs or compounds that selectively clear senescent cells that accumulate with aging and drive inflammation. Early human trials show safety and some biomarker effects.

Mixed / ongoing studies Senescent cell targeting Read more →

Stem Cell Therapy

Deploying stem cells or cell-derived factors to regenerate damaged tissue or restore declining cell populations. Highly indication-specific -- some uses are clinically established, longevity applications are investigational.

Varies by use case Regenerative medicine Read more →

Gene Therapy

Modifying gene expression related to longevity pathways such as telomere maintenance, DNA repair, or mTOR signaling. Some early human self-experiments; no established longevity protocols.

Early / indication-specific Genetic intervention Read more →

Related Articles

Age Reversal Technology with AI Cellular Reprogramming and Age Reversal Senolytics: Clearing Senescent Cells
Age Reversal Longevity Science Longevity Companies
Research publication: Evidence levels are noted per entry. This content is for educational purposes and does not constitute medical advice. Data reflects current research status and is updated as the field evolves.